CIENCIAS FARMACÉUTICAS
Departamento
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (7)
2024
-
Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis
Gastroenterologia y Hepatologia, Vol. 47, Núm. 5, pp. 522-552
2023
-
Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research
-
Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
Pharmacological Research, Vol. 194
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2021
-
Pharmacogenetics of trough serum anti-TNF levels in paediatric inflammatory bowel disease
British Journal of Clinical Pharmacology, Vol. 87, Núm. 2, pp. 447-457
1999
-
Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: Molecular survey by regions
European Journal of Human Genetics, Vol. 7, Núm. 3, pp. 386-392